Company
Technology
Team
Board of Directors
Management
Extended Management
Project Management
Partners & Advisors
Preclinical Research
Clinical Research
Strategic Investment
Investors
News
Company News
Scientific Publications
Contact
19 August 2021
L’Avenir: “Two new vaccines are expected in late 2021”
“Two new vaccines against COVID-19, using the recombinant protein technique, could be added to the vaccine range by the end of the year. One of them will be a Swiss vaccine: RocketVax.”
PREVIOUS NEWS
NEXT NEWS
SHARE THIS NEWS